Translational Development...

NASDAQ: TDAC · Real-Time Price · USD
10.32
0.00 (0.00%)
At close: Aug 15, 2025, 10:41 AM

Translational Development Acquisition Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-71.01K -485.55K -70.66
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a
Other Working Capital
-210.06K 3.01K -75.08
Other Non-Cash Items
-120.63K 482.34K 0.00
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-659.81K 3.01K -75.08
Operating Cash Flow
-851.45K -204 -145.75
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
-174.22M n/a n/a
Investing Cash Flow
-174.22M n/a n/a
Debt Repayment
-393.46K n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
-125.35K n/a n/a
Other Financial Acitivies
6.98M n/a 149.08
Financial Cash Flow
175.51M n/a 149.08
Net Cash Flow
436.15K -204 n/a
Free Cash Flow
-851.45K -204 -145.75